 |
 |
GEO help: Mouse over screen elements for information. |
|
| Status |
Public on Feb 07, 2024 |
| Title |
A novel inhibitor of P. aeruginosa folate metabolism exploits metabolic differences for narrow-spectrum antibiotic targeting |
| Organism |
Pseudomonas aeruginosa |
| Experiment type |
Expression profiling by high throughput sequencing
|
| Summary |
Pseudomonas aeruginosa is a leading cause of hospital acquired infections for which the development of new antibiotics is urgently needed. Unlike most enteric bacteria, P. aeruginosa lacks thymidine kinase and thymidine phosphorylase activity, and thus cannot scavenge exogenous thymine. An appealing strategy to selectively target P. aeruginosa while leaving the healthy microbiome largely intact would thus be to disrupt thymidine synthesis while providing exogenous thymine. However, this approach was previously intractable because known antibiotics that perturb thymidine synthesis are largely inactive against P. aeruginosa. Here, we characterize a novel dihydrofolate reductase inhibitor, fluorofolin, that exhibits significant activity against P. aeruginosa in culture and in a mouse thigh infection model. Fluorofolin is active against a wide range of clinical P. aeruginosa isolates resistant to known antibiotics, including critical antibiotic development priorities expressing the beta-lactamases KPC-5 and NDM-1. Importantly, in the presence of thymine supplementation, fluorofolin activity is selective for P. aeruginosa. Resistance to fluorofolin can emerge through overexpression of the efflux pumps MexCD-OprJ and MexEF-OprN. However, these mutants also decrease pathogenesis, in part due to increased export of quorum sensing precursors leading to decreased virulence factor production. Our findings thus demonstrate how understanding species-specific genetic differences and discovery of an antibiotic with a widely conserved target can enable selective targeting of important pathogens while revealing new tradeoffs between resistance and pathogenesis.
|
| |
|
| Overall design |
To verify the phenotype of two flurofolin resistant mutants in P. Aeruginosa
|
| |
|
| Contributor(s) |
Chain C, Sheehan JP, Xu X, Ghaffari S, Godbole A, Kim H, Freundlich JS, Rabinowitz JD, Gitai Z |
| Citation(s) |
38594311 |
| Submission date |
Dec 11, 2023 |
| Last update date |
May 08, 2024 |
| Contact name |
Connor Chain |
| E-mail(s) |
husovsky@princeton.edu
|
| Organization name |
Princeton University
|
| Street address |
Lewis Thomas Lab
|
| City |
Princeton |
| ZIP/Postal code |
08540 |
| Country |
USA |
| |
|
| Platforms (1) |
| GPL33271 |
NextSeq 2000 (Pseudomonas aeruginosa) |
|
| Samples (3) |
|
| Relations |
| BioProject |
PRJNA1051048 |
| Supplementary file |
Size |
Download |
File type/resource |
| GSE249862_Counts.xlsx |
184.0 Kb |
(ftp)(http) |
XLSX |
SRA Run Selector |
| Raw data are available in SRA |
|
|
|
|
 |
